Immune cellular parameters of leprosy and human immunodeficiency virus-1 co-infected subjects

Immunology

Volumn 124, Issue 2, 2008, Pages 206-214

  Carvalho, Karina I ^a   Maeda, Solange ^a   Marti, Luciana ^b   Yamashita, Jane ^a   Haslett, Patrick A J ^c   Kallas, Esper G ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Albert Einstein Research and Education Institute   (Brazil)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

Co infection; HIV; IL 4; Leprosy; Lymphocytes

Indexed keywords

INTERLEUKIN 4;

ADULT; ARTICLE; CD4 CD8 RATIO; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CELLULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LEPROSY; MALE; MYCOBACTERIUM LEPRAE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

ADULT; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DENDRITIC CELLS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-4; LEPROSY; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RNA, VIRAL; T-LYMPHOCYTE SUBSETS; VIRAL LOAD;

EID: 43749087317     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2007.02756.x     Document Type: Article

References (45)

1. Lockwood DN, Kumar B. Treatment of leprosy. BMJ 2004 328 : 1447 8.
2. Meima A, Smith WC, van Oortmarssen GJ, Richardus JH, Habbema JD. The future incidence of leprosy: a scenario analysis. Bull World Health Organ 2004 82 : 373 80.
3. Pereira GA, Stefani MM, Araujo Filho JA, Souza LC, Stefani GP, Martelli CM. Human immunodeficiency virus type 1 (HIV-1) and Mycobacterium leprae co-infection: HIV-1 subtypes and clinical, immunologic, and histopathologic profiles in a Brazilian cohort. Am J Trop Med Hyg 2004 71 : 679 84.
4. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986 136 : 2348 57.
5. Modlin RL. Th1-Th2 paradigm: insights from leprosy. J Invest Dermatol 1994 102 : 828 32.
6. Bloom BR. Learning from leprosy: a perspective on immunology and the Third World. J Immunol 1986 137 : i x.
7. Ustianowski AP, Lawn SD, Lockwood DN. Interactions between HIV infection and leprosy: a paradox. Lancet Infect Dis 2006 6 : 350 60.
8. Toossi Z, Mayanja-Kizza H, Hirsch CS et al. Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients. Clin Exp Immunol 2001 123 : 233 8.
9. Whalen C, Horsburgh CR, Hom D, Lahart C, Simberkoff M, Ellner J. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 1995 151 : 129 35.
10. Nath I, Vemuri N, Reddi AL, Jain S, Brooks P, Colston MJ, Misra RS, Ramesh V. The effect of antigen presenting cells on the cytokine profiles of stable and reactional lepromatous leprosy patients. Immunol Lett 2000 75 : 69 76.
11. Sampaio EP, Caneshi JR, Nery JA et al. Cellular immune response to Mycobacterium leprae infection in human immunodeficiency virus-infected individuals. Infect Immun 1995 63 : 1848 54.
12. Gormus BJ, Murphey-Corb M, Baskin GB, Uherka K, Martin LN, Marx PA, Xu K, Ratterree MS. Interactions between Mycobacterium leprae and simian immunodeficiency virus (SIV) in rhesus monkeys. J Med Primatol 2000 29 : 259 67.
13. Eberl M, Hintz M, Reichenberg A, Kollas AK, Wiesner J, Jomaa H. Microbial isoprenoid biosynthesis and human gammadelta T cell activation. FEBS Lett 2003 544 : 4 10.
14. Barnes PF, Grisso CL, Abrams JS, Band H, Rea TH, Modlin RL. Gamma delta T lymphocytes in human tuberculosis. J Infect Dis 1992 165 : 506 12.
15. Fujita M, Miyachi Y, Nakata K, Imamura S. Appearance of gamma delta T cell receptor-positive cells following alpha beta T cell receptor-positive cells in the lepromin reaction of human skin. Immunol Lett 1993 35 : 39 44.
16. Poccia F, Gougeon ML, Agrati C et al. Innate T-cell immunity in HIV infection: the role of Vgamma9Vdelta2 T lymphocytes. Curr Mol Med 2002 2 : 769 81.
17. Poles MA, Barsoum S, Yu W et al. Human immunodeficiency virus type 1 induces persistent changes in mucosal and blood gammadelta T cells despite suppressive therapy. J Virol 2003 77 : 10456 67.
18. Pulendran B. Modulating TH1/TH2 responses with microbes, dendritic cells, and pathogen recognition receptors. Immunol Res 2004 29 : 187 96.
19. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan F, Liu YJ. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001 194 : 863 9.
20. Krutzik SR, Ochoa MT, Sieling PA et al. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat Med 2003 9 : 525 32.
21. Bafica A, Scanga CA, Feng CG, Leifer C, Cheever A, Sher A. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J Exp Med 2005 202 : 1715 24.
22. Levy JA, Scott I, Mackewicz C. Protection from HIV/AIDS: the importance of innate immunity. Clin Immunol 2003 108 : 167 74.
23. Organizaton WH. Chemotherapy of leprosy for control programme, report of WHO study group. WHO TechRepSer 1982 675 : 1 33.
24. Saúde MD. Recomendações para Terapia Anti-Retroviral em Adultos e Adolescentes Infectados pelo HIV. Brasília-DF : Ministério da Saúde, 2006 : 1 85.
25. Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 1966 34 : 255 73.
26. Hirsch HH, Kaufmann G, Sendi P, Battegay M. Immune reconstitution in HIV-infected patients. Clin Infect Dis 2004 38 : 1159 66.
27. Goebel FD. Immune reconstitution inflammatory syndrome (IRIS) - another new disease entity following treatment initiation of HIV infection. Infection 2005 33 : 43 5.
28. Couppie P, Abel S, Voinchet H, Roussel M, Helenon R, Huerre M, Sainte-Marie D, Cabie A. Immune reconstitution inflammatory syndrome associated with HIV and leprosy. Arch Dermatol 2004 140 : 997 1000.
29. Roederer M. Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. Cytometry 2001 45 : 194 205.
30. Kallas EG, Gibbons DC, Soucier H, Fitzgerald T, Treanor JJ, Evans TG. Detection of intracellular antigen-specific cytokines in human T cell populations. J Infect Dis 1999 179 : 1124 31.
31. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999 401 : 708 12.
32. Stenger S, Modlin RL. T cell mediated immunity to Mycobacterium tuberculosis. Curr Opin Microbiol 1999 2 : 89 93.
33. Antas PR, Sales JS, Pereira KC, Oliveira EB, Cunha KS, Sarno EN, Sampaio EP. Patterns of intracellular cytokines in CD4 and CD8 T cells from patients with mycobacterial infections. Braz J Med Biol Res 2004 37 : 1119 29.
34. Sousa AE, Chaves AF, Doroana M, Antunes F, Victorino RM. Bulk cytokine production versus frequency of cytokine-producing cells in HIV1 infection before and during HAART. Clin Immunol 2000 97 : 162 70.
35. Yamamura M, Wang XH, Ohmen JD, Uyemura K, Rea TH, Bloom BR, Modlin RL. Cytokine patterns of immunologically mediated tissue damage. J Immunol 1992 149 : 1470 5.
36. Barnes PF, Abrams JS, Lu S, Sieling PA, Rea TH, Modlin RL. Patterns of cytokine production by mycobacterium-reactive human T-cell clones. Infect Immun 1993 61 : 197 203.
37. de Castro Cunha RM, Kallas EG, Rodrigues DS, Nascimento Burattini M, Salomao R. Interferon-gamma and tumour necrosis factor-alpha production by CD4+ T and CD8+ T lymphocytes in AIDS patients with tuberculosis. Clin Exp Immunol 2005 140 : 491 7.
38. Rodrigues DS, Medeiros EA, Weckx LY, Bonnez W, Salomao R, Kallas EG. Immunophenotypic characterization of peripheral T lymphocytes in Mycobacterium tuberculosis infection and disease. Clin Exp Immunol 2002 128 : 149 54.
39. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004 22 : 745 63.
40. Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991 254 : 277 9.
41. Salgame P, Abrams JS, Clayberger C, Goldstein H, Convit J, Modlin RL, Bloom BR. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 1991 254 : 279 82.
42. Galli G, Annunziato F, Mavilia C et al. Enhanced HIV expression during Th2-oriented responses explained by the opposite regulatory effect of IL-4 and IFN-gamma of fusin/CXCR4. Eur J Immunol 1998 28 : 3280 90.
43. Sieling PA, Abrams JS, Yamamura M, Salgame P, Bloom BR, Rea TH, Modlin RL. Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J Immunol 1993 150 : 5501 10.
44. Mitra DK, De Rosa SC, Luke A et al. Differential representations of memory T cell subsets are characteristic of polarized immunity in leprosy and atopic diseases. Int Immunol 1999 11 : 1801 10.
45. Stutz A, Graf P, Beinhauer B, Hammerschmid F, Neumann C, Woisetschlager M, Jung T. CD45 isoform expression is associated with different susceptibilities of human naive and effector CD4+ T cells to respond to IL-4. Eur J Immunol 2005 35 : 575 83.